Smarter, aster, better: How AI is reshaping neuroscience clinical trials

How can neuroscience clinical trial sponsors use AI to reduce complexity, accelerate timelines and lower costs in a high-risk, delay-prone research environment?

Cortex Conversations: Insights in Neuroscience, Series 4

Choosing the right AI vendor for clinical trials in a rapidly evolving landscape

Choosing the right AI vendor can transform your clinical trial strategy. Explore key questions to shape effective, future-ready collaborations.

AI can find the patients-but can humans reach them?

If AI can rapidly identify eligible patients for ophthalmology clinical trials, what strategies must sponsors, CROs and research sites adopt to overcome human and operational barriers and full realize AI's potential in patient recruitment?

How can AI in ophthalmology transform each critical stage of your trial journey?

How can AI in ophthalmology transform each critical stage of your trial journey?

Pricing and reimbursement in Italy: At a glance

Pricing and reimbursement processes in Italy

Accelerated submission in rare disease: A Fortrea FSP case study

A small U.S.-based biotech company that’s focused on rare disease treatment needed to accelerate their Biologics License Application (BLA) submission timelines. With Fortrea’s Functional Service Provider (FSP) experience added to their team, they successfully met complex regulatory demands, rapidly scaled global resources and completed their accelerated submission on schedule.

Common sources of design flaws in clinical trials protocols